CYTOMEL T3

NOVO-PHARM CYTOMEL T3 GENERAL DESCRIPTION

Triiodothyronine (T3) is the thyroid hormone that is most active. It’s not part of anabolic or androgen categories. Liothyronine sodium serves as the main active agent of the drug, which is similar in its effects on the body to the natural thyroid hormone L-T3 (L-triiodothyronine). This hormone is popular as a way of stimulating metabolism in bodybuilding. The drug is often used for cutting, but it can also be used to gain muscle. Triiodothyronine has the ability to bind to androgen receptors, which has a positive effect on fat burning.

NOVO-PHARM CYTOMEL T3 BENEFITS

Bodybuilders use triiodothyronine to promote metabolism, resulting in increased fat, protein, and carbohydrate metabolism. Thyroid hormone induces lipolysis — the rapid burning of subcutaneous fat. Triiodothyronine is used before a championship during pre-competitive periods, allowing consumers to achieve the best possible body image and low body fat without a low calorie diet.

Athletes using the drug at low dosages show greater effectiveness of concurrently used steroids triggered by the absorption of the stimulated protein. Thyroid gland hyperstimulation allows users to burn large quantities of calories. In some situations, for maximum results, triiodothyronine can be used along with Clenbuterol.

The thyroid hormone itself has the following beneficial effects on the body:

• stimulated metabolism;
• increased body heat, which accelerates fat burning;
• reduced subcutaneous fat deposits;
• stimulated central nervous system function;
• reduced appetite;
• decreased need for sleep;
• improved physical performance.

When compared to other fat burners, Triiodothyronine is superior to all known drugs.

NOVO-PHARM CYTOMEL T3 POSSIBLE SIDE EFFECTS

Exceeded dosages or individual intolerances to the drug may lead to negative reactions like rapid heartbeat, impaired heart rate, feeling of uneasiness, asthma attacks, hyperhidrosis, diarrhea, increased sugar amount in urine, hypersensitivity of the skin, feeling of constant pressure in the heart, disturbed mental state, major weight loss. Most often bodybuilders record upper extremity tremor, frequent headaches, palpitations and excessive sweating. Through reducing the normal dosages, adverse drug reactions are quickly avoided. Nonetheless, when using T3, caution should be exercised, as this drug is a means of rapid action.

NOVO-PHARM CYTOMEL T3 ADMINISTRATION AND DOSAGE

A Triiodothyronine cycle will begin gradually, at 25 mcg (half a tablet) for the initial dosages. In the first days of the cycle, it is also possible to take a quarter tablet – 12.5 mcg. Dosages must be gradually increased every 2-4 days and eventually reach the maximum daily dose of 75 mcg.

Half-life of triiodothyronine is 2-3 days, but this does not mean that after one day and a half of the 25 mcg 12.5 of those administered will remain active. After administration, the peak concentration is reached in 5-7 hours and then gradually decreases. This means that users should not take the entire daily dose in the morning, as maintaining equal hormonal levels throughout the day is necessary. In the morning and afternoon, it is possible to split the dose into two administrations. The dosage can be divided into 3 doses to promote sensitivity to the drug.

The dosage of the drug should be gradually reduced at the end of the cycle to prevent a sharp end of the intake of hormones. The length of use of the medication should be 3-4 weeks. Using Triiodothyronine for no more than 6 weeks is recommended. There should be a break of at least two months between repeated cycles. Athletes who use high doses of the hormone for long periods of time are at risk.

During the cycle, body temperature, blood pressure and heart rate should be controlled. Overcoming normal values can mean a disruption to the body’s function. If the body temperature approaches 39 degrees and the heart rate is more than 100 beats during the rest period, it suggests a high loss of muscle mass and the initiation of thyroid damage.

Post-cycle therapy is important for restoring the thyroid gland so that the body can generate hormones independently when using thyroid hormones. Alternatively, after discontinuing the use of the medication, body fat can accumulate rapidly. PCT should last 45 days (one and a half months), with Tyrosine at 2000 mg daily, split into 2 admissions in the morning and in the evening, Gugulipid is used at 35 mg three times per day and Resveratrol at 100 mg daily.

Triiodothyronine can lead to a rapid loss of muscle mass for several weeks. A moderate dose of testosterone may stop or slow this process significantly, which is why the drug is often used in combination with anabolic steroids. Triiodothyronine requires a limited amount of proteins in its metabolic processes as part of such a combined cycle, so patients must adopt a high protein diet.

Simultaneous use of steroids with triiodothyronine results in accelerated conversion of androgens to estrogens in the tissues and increased free globulin concentration responsible for binding sex hormones, which raises estrogen concentration. This effect may result in gynecomastia during the cycle, so aromatase inhibitors should be used as the first signs of aromatization begin to appear.